RCM
AEON.WS

Rivernorth Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Rivernorth Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-44,868
Closed -$3.59K – 494
2023
Q4 		$3.59K Hold
44,868
– – ﹤0.01% 394
2023
Q3 		$2.34K Hold
44,868
– – ﹤0.01% 486
2023
Q2 		$4.04K Hold
44,868
– – ﹤0.01% 484
2023
Q1 		$2.69K Buy
44,868
+31,536
+237% +$1.82K ﹤0.01% 578
2022
Q4 		$667 Hold
13,332
– – ﹤0.01% 701
2022
Q3 		$1K Hold
13,332
– – ﹤0.01% 841
2022
Q2 		$2K Hold
13,332
– – ﹤0.01% 788
2022
Q1 		$4K Hold
13,332
– – ﹤0.01% 803
2021
Q4 		$7K Hold
13,332
– – ﹤0.01% 709
2021
Q3 		$7K Buy
+13,332
New +$9.77K ﹤0.01% 560

Other funds holding AEON.WS

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

Rivernorth Capital Management's AEON.WS Position: Q1 2024 in Review

Rivernorth Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q1 2024, closing a stake of 44,868 shares — an estimated $3.59K sold.

Rivernorth Capital Management first reported a position in AEON.WS in Q3 2021 and held it in 10 quarters. The position peaked at $7K in Q4 2021. 30 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2024.

  • Rivernorth Capital Management reported no remaining AEON Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Rivernorth Capital Management sold 44,868 AEON Biopharma Inc shares in Q1 2024, an estimated $3.59K.
  • Rivernorth Capital Management first reported a position in AEON Biopharma Inc in Q3 2021 and held it in 10 quarters.
  • Rivernorth Capital Management's AEON Biopharma Inc position peaked at $7K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2024.

Based on Rivernorth Capital Management's 13F filing for Q1 2024, filed 15 May 2024.